Ferring Pharmaceuticals appoints Alex Chang Senior Vice President, Asia Pacific
- by pulseFerring Pharmaceuticals announced today that it has appointed Alex Chang to head the company’s Asia Pacific region effective 1 November 2013…
pulseMISODEL™, Ferring’s removable misoprostol vaginal delivery system, approved for labour induction in European Decentralised Procedure
- by pulseFerring Pharmaceuticals announced today that its MISODELTM (misoprostol) removable, controlled-release vaginal delivery system for labour induction…
pulseFerring announces second $3 million donation to the Royal Textile Academy of Bhutan
- by pulseFerring Pharmaceuticals has announced a second $3 million donation to the Royal Textile Academy of Bhutan to support its mission to preserve and…
pulseFerring presents phase III data for a controlled release misoprostol vaginal delivery system for labour induction at the First European Congress on Intrapartum Care
- by pulseData from the EXPEDITE study presented today at the First European Congress on Intrapartum Care (ECIC) demonstrated…
pulseFerring Pharmaceuticals begins phase III trials of elobixibat, new compound with novel mechanism of action for chronic idiopathic constipation
- by pulseFerring Pharmaceuticals today announced it has initiated enrolment of patients in two phase III clinical trials…
pulse
- 1
- 2